Covalon Technologies (CVE:COV) Trading Down 15% - Time to Sell?

Covalon Technologies Ltd. (CVE:COV - Get Free Report) traded down 15% during mid-day trading on Tuesday . The stock traded as low as C$2.80 and last traded at C$3.05. 188,058 shares were traded during mid-day trading, an increase of 115% from the average session volume of 87,410 shares. The stock had previously closed at C$3.59.

Covalon Technologies Stock Performance

The company has a quick ratio of 6.45, a current ratio of 5.24 and a debt-to-equity ratio of 4.98. The company has a market capitalization of C$90.15 million, a PE ratio of -82.25 and a beta of 0.64. The company has a 50-day moving average price of C$3.54 and a two-hundred day moving average price of C$3.02.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.